fendiline has been researched along with Fibrodysplasia Ossificans Progressiva in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, R | 1 |
| Matsushita, M | 1 |
| Kitoh, H | 1 |
| Masuda, A | 1 |
| Ito, M | 1 |
| Katagiri, T | 1 |
| Kawai, T | 1 |
| Ishiguro, N | 1 |
| Ohno, K | 1 |
1 other study available for fendiline and Fibrodysplasia Ossificans Progressiva
| Article | Year |
|---|---|
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.
Topics: Activin Receptors, Type I; Animals; Bone Morphogenetic Protein 2; Calcium Channel Blockers; Cell Lin | 2013 |